Amundi Corcept Therapeutics Inc Transaction History
Amundi
- $275 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding CORT
# of Institutions
368Shares Held
86.8MCall Options Held
1.12MPut Options Held
667K-
Black Rock Inc. New York, NY16.5MShares$1.13 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$689 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.1MShares$552 Million16.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.51MShares$443 Million0.48% of portfolio
-
Parallel Advisors, LLC3.83MShares$261 Million4.44% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $7.29B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...